-+ 0.00%
-+ 0.00%
-+ 0.00%

GSK CEO: WE DON'T NEED THIS NUVALENT DEAL TO ACHIEVE £40 BILLION SALES TARGET BY 2031

Reuters·06/09/2026 07:11:41

Please log in to view news